Aurobindo Pharma to Launch Rs 800 Crore Share Buyback Programme on April 23

Aurobindo Pharma Sets April 23 as Opening Date for Rs 800 Crore Buyback Offer

Aurobindo Pharma Ltd has announced that it will begin its Rs 800 crore buyback offer on April 23. The closing date for the buyback has been set as April 29, according to a regulatory filing submitted by the company.

The company's board had approved the buyback of up to 54,23,728 fully paid-up equity shares with a face value of Re 1 each at a price of Rs 1,475 per share on a proportionate basis through the tender offer route on April 6. The record date for determining the entitlement and the names of eligible equity shareholders has been set as April 17.

The buyback size represents 3.93 per cent of the aggregate of the total paid-up equity share capital and free reserves, including securities premium, of the company as per the audited standalone financial statements as of March 31, 2025. It also accounts for 2.62 per cent of the same aggregate as per the audited consolidated financial statements.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In a letter to shareholders, Aurobindo Pharma explained that the buyback is intended to reward shareholders and enhance their overall return, while also improving earnings per share and other key ratios such as return on net worth and return on assets over time. The company assured that the buyback will not result in a change in control or affect the existing management structure.